fibrinogen, human�chmt (FESILTY)
fibrinogen, human�chmt is an FDA-licensed reference biologic from Grifols Therapeutics LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2025
Reference approved
Reference product
FESILTY fibrinogen, human�chmt
Grifols Therapeutics LLC
- Approved
- Dec 16, 2025
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for fibrinogen, human�chmt, in chronological order.
Reference approval
Approval date of the reference fibrinogen, human�chmt product.
6 mo ago
Frequently asked questions
Are there biosimilars approved for fibrinogen, human�chmt (FESILTY)?
No 351(k) biosimilars or interchangeable biosimilars referencing fibrinogen, human�chmt are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.